Fertility and Sterility
Volume 77 , Pages 49-54 , April 2002

Randomized clinical trials of combined estrogen-androgen preparations: effects on sexual functioning

  • Barbara B Sherwin, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Barbara B. Sherwin, Ph.D., Department of Psychology, McGill University, Stewart Biology Building, 1205 Dr. Penfield Ave., Montreal, Quebec, H3A 1B1 Canada (FAX: 514-398-4896)
    • Departments of Psychology and Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada

Received 16 October 2001 ,Revised 22 January 2002 ,Accepted 22 January 2002.

References 

  1. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone dehydroepiandrosterone sulphate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;85:2832–2838
  2. McEwen BS. The brain as a target organ of endocrine hormones. In:  Kreiger DT,  Hughes JS editor. Neuroendocrinology. Sutherland MA: Sinauer Assoc; 1989;p. 33–42
  3. Celotto F, Melcangi RC, Negri-Cesi P , Poletti A. Testosterone metabolism in brain cells and membranes. J Steroid Biochem Mol Biol. 1991;40:673–678
  4. Anderson DCP. Sex hormone-binding globulin. Clin Endocrinol. 1974;3:69–74
  5. Everitt BJ, Herbert J. The effects of implanting testosterone propionate in the central nervous system on the sexual behavior of the female rhesus monkeys. Brain Res. 1975;86:109–120
  6. Leiblum S, Bachmann G, Kemmann E, Colburn DS, Swartzmann L. Vaginal atrophy in the postmenopausal woman (the importance of sexual activity and hormones). J Am Med Assoc. 1984;249:2195–2198
  7. McCoy N, Davidson J. A longitudinal study of the effects of menopause on sexuality. Marituritas. 1985;7:203–210
  8. Flöter A, Nathorst-Böös J , Carlstrom K, von Schoultz B . Androgen status and sexual life in perimenopausal women. Menopause. 1997;95–100
  9. Dennerstein L, Smith AMS, Morse CA, Bourger HG. Sexuality and the menopause. J Psychosom Obstet Gynaecol. 1994;15:59–66
  10. Hallstrom T. Sexuality in the climacteric. Clin Obstet Gynecol. 1977;4:227–239
  11. Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas. 1977;26:83–93
  12. Cawood EHH, Bancroft J. Steroid hormones. The menopause, sexuality and well-being of women. Psychol Med. 1996;26:925–936
  13. Burger HG, Hailles J, Menelaus M, Nelson J, Hudson B, Balasz N. The management of persistent menopausal symptoms with oestradiol testosterone implants (clinical, lipid and hormonal results). Maturitas. 1984;6:35l–358
  14. Burger HG, Hailes J, Nelson J, Menelaus M. Effects of combined implants of estradiol and testosterone on libido in postmenopausal women. Br Med J. 1987;294:936–937
  15. Davis SR, McClaud P, Strauss BJG, Burger H. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas. 1995;21:227–236
  16. Longcope C. Metabolism clearance and blood production rates of estrogen in postmenopausal women. Am J Obstet Gynecol. 1981;111:779–785
  17. Sherwin BB, Gelfand MM. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol. 1985;151:153–160
  18. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affective Dis. 1988;14:177–187
  19. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females (A prospective cross-over study of sex steroid administration in the surgical menopause). Psychosom Med. 1985;7:339–351
  20. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1987;49:397–409
  21. Sherwin BB. Changes in sexual behavior as a function of plasma sex steroid levels in post-menopausal women. Maturitas. 1985;7:225–233
  22. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-alone therapy. J Reprod Med. 1998;43:847–856
  23. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al.  Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682–688
  24. Phillips E, Bauman C. Safety surveillance of esterified estrogens-methylthestosterone (Estratest and Estratest HS) replacement therapy in the United States. Clin Ther. 1997;19:1070–1084
  25. Estratest Working Group Barrett-Connor E , Timmons C, Young R, Wiita B. Interim safety of a two-year study comparing oral estrogen-androgen and conjugated estrogens in surgically menopausal women. J Women’s Health. 1996;5:593–602
  26. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms and lipid-lipoprotein profiles in surgical menopausal women. Obstet Gynecol. 1995;85:529–537
  27. Hickok LR, Toomey C, Speroff L. A comparison of esterified estrogens with and without methyltestosterone (Effects on endometrial histology and serum lipoproteins in postmenopausal women). Obstet Gynecol. 1993;82:919–924
  28. Yue P, Chatterkee K, Beale C. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91:1154–1160
  29. Honoré EH, Williams JK, Adams MR, Ackerman DM, Wager JD. Methyltestosterone does not diminish the beneficial effects of estrogen replacement therapy on coronary artery reactivity in cynomolgus monkeys. Menopause. 1996;3:20–26
  30. Sherwin BB, Gelfand MM, Schucher R, Gabor J. Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations. An J Obstet Gynecol. 1987;156:414–419
  31. Farish E, Fletcher CD, Hart DM, et al.  The effect of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomized women. Acta Endocrinol. 1984;106:116–123
  32. Gelfand MM, Ferenczy A, Bergeron C. Endometrial response to estrogen-androgen stimulation. In:  Hamond CB,  Haseltine FB,  Seniff I editor. Menopause evaluation, treatment and health concerns. New York: Alan R. Liss; 1989;p. 29–40

☆ The preparation of this manuscript was supported by a grant from the Canadian Institutes for Health Research (No. MA-11623) awarded to Dr. Barbara B. Sherwin.

PII: S0015-0282(02)03002-9

Fertility and Sterility
Volume 77 , Pages 49-54 , April 2002

Article Tools